Sonoma Pharmaceuticals, Inc.
SNOA
$1.33
$0.010.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.34M | 2.40M | 2.56M | 3.04M | 3.61M |
| Total Receivables | 3.18M | 2.61M | 2.53M | 2.91M | 2.83M |
| Inventory | 3.79M | 3.65M | 3.70M | 3.63M | 3.80M |
| Prepaid Expenses | 3.96M | 3.44M | 3.35M | 2.93M | 2.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.27M | 12.10M | 12.15M | 12.50M | 13.11M |
|
|
|||||
| Total Current Assets | 16.27M | 12.10M | 12.15M | 12.50M | 13.11M |
| Net Property, Plant & Equipment | 868.00K | 912.00K | 956.00K | 763.00K | 837.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 971.00K | 948.00K | 522.00K | 592.00K | 650.00K |
| Total Assets | 18.11M | 13.96M | 13.62M | 13.86M | 14.59M |
|
|
|||||
| Total Accounts Payable | 2.19M | 1.92M | 1.65M | 1.40M | 2.05M |
| Total Accrued Expenses | 2.67M | 1.72M | 2.11M | 2.02M | 1.84M |
| Short-term Debt | 140.00K | 222.00K | -- | 56.00K | 139.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 160.00K | 151.00K | 146.00K | 88.00K | 96.00K |
| Total Finance Division Other Current Liabilities | 282.00K | 817.00K | 314.00K | 750.00K | 731.00K |
| Total Other Current Liabilities | 282.00K | 817.00K | 314.00K | 750.00K | 731.00K |
| Total Current Liabilities | 5.45M | 4.83M | 4.22M | 4.32M | 4.85M |
|
|
|||||
| Total Current Liabilities | 5.45M | 4.83M | 4.22M | 4.32M | 4.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 140.00K | 222.00K | -- | 56.00K | 139.00K |
| Capital Leases | 439.00K | 469.00K | 509.00K | 391.00K | 440.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.63M | 5.56M | 5.47M | 5.36M | 5.25M |
| Total Liabilities | 11.51M | 10.87M | 10.19M | 10.07M | 10.54M |
|
|
|||||
| Common Stock & APIC | 210.91M | 207.32M | 207.02M | 206.73M | 206.67M |
| Retained Earnings | -201.31M | -200.98M | -200.40M | -199.58M | -199.05M |
| Treasury Stock & Other | -3.01M | -3.24M | -3.19M | -3.37M | -3.57M |
| Total Common Equity | 6.59M | 3.10M | 3.43M | 3.79M | 4.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.59M | 3.10M | 3.43M | 3.79M | 4.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.59M | 3.10M | 3.43M | 3.79M | 4.06M |
|
|
|||||